Atorvastatin in Factorial with Omega-3 EE90 Risk Reduction in Diabetes (AFORRD): a randomised controlled trial

✍ Scribed by R. R. Holman; S. Paul; A. Farmer; L. Tucker; I. M. Stratton; H. A. W. Neil; on behalf of the AFORRD study group

• Publisher: Springer
• Year: 2008
• Tongue: English
• Weight: 207 KB
• Volume: 52
• Category: Article
• ISSN: 0012-186X
• DOI: 10.1007/s00125-008-1179-5